SiO2 Scales Manufacturing of Hybrid Vial Capacity for 400 Million Doses of COVID-19 Vaccine Achieved Ahead of Schedule

AUBURN, Ala., July 2, 2020 /PRNewswire/ — SiO2 Materials Science, a privately-owned US-based advanced materials science company, today announced they have successfully scaled their